Lappadilactone

Lappadilactone

SCHEMBL29659614

C=C1CC[C@H]2C(=C)CC[C@@H]3[C@H](OC(=O)[C@@]3(O)C[C@]3(C)CCC(=O)[C@]4(C)CC[C@H]5C(=C)C(=O)O[C@@H]5[C@@H]34)[C@@H]12

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PKM P14618 7/20 0.37
▸ NLRP3 Q96P20 2/20 0.37
▸ PAX8 Q06710 1/20 0.33
▸ ALDH1A1 P00352 4/20 0.32
▸ LMNA P02545 3/20 0.32
▸ TP53 P04637 3/20 0.32
▸ CYP3A4 P08684 3/20 0.32
▸ MAPT P10636 3/20 0.32
▸ NFKB1 P19838 2/20 0.32
▸ CYP1A2 P05177 2/20 0.32
▸ STAT6 P42226 2/20 0.32
▸ MAPK1 P28482 2/20 0.32
▸ HTT P42858 2/20 0.32
▸ CASP1 P29466 1/20 0.32
▸ PTGS2 P35354 1/20 0.32
▸ NFKB2 Q00653 1/20 0.32
▸ RELA Q04206 1/20 0.32
▸ CYP2D6 P10635 1/20 0.32
▸ TSHR P16473 1/20 0.32
▸ THPO P40225 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19361211 0.72 CYP3A4 (0.30) CYP3A4
Lappalone SCHEMBL29554118 0.70 PTPN1 (0.31) CYP3A4
Dehydrocostuslactone SCHEMBL31029489 0.68 CYP19A1 (0.46) PKMNLRP3ALDH1A1LMNATP53
Dehydrocostuslactone SCHEMBL936050 0.68 CYP19A1 (0.46) PKMNLRP3ALDH1A1LMNATP53
Dehydrocostuslactone SCHEMBL699070 0.68 CYP19A1 (0.46) PKMNLRP3ALDH1A1LMNATP53
SCHEMBL17147754 0.65 PKM (0.55) PKMNLRP3PAX8ALDH1A1LMNA
SCHEMBL17147746 0.65 PKM (0.55) PKMNLRP3PAX8ALDH1A1LMNA
SCHEMBL29368384 0.64 PKM (0.44) PKMNLRP3ALDH1A1LMNATP53
SCHEMBL12516833 0.61 — —
SCHEMBL31169568 0.59 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024189607-A1 METHODS AND BIOAVAILABLE HIGHLY PERMEABLE COMPOUNDS FOR DISEASES TREATMENT DIDENKO KIRILL (MX) 2024-09-19 — — WO disclosed
CN-114496301-A Use of compositions in the treatment of Crohn's disease 安徽誉隆亚东药业有限公司 2022-05-13 — — CN disclosed
Send feedback